Exact Sciences Corporation (NASDAQ:EXAS) recovered 327.82% of its value since hitting low of $13.05. The recent move of 7.8% gain helped the stock to close at $55.83 when trading ended on 01/03/2018. At recent session, the prices were hovering between $51.85 and $56.09. This company shares are 5.86% off its target price of $59.1 and the current market capitalization stands at $6.95B. The recent change has given its price a 1.69% lead over SMA 50 and -12.22% deficit over its 52-week high. The stock witnessed -3.66% declines, 13.66% gains and 54.78% gains for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found EXAS’s volatility during a week at 5.07% and during a month it has been found around 4.26%.Exact Sciences Corporation (EXAS) Top Holders
Institutional investors currently hold around $5.11 billion or 84.5% in EXAS stock. Look at its top three institutional owners. Vanguard Group Inc owns $503.19 million in Exact Sciences Corporation, which represents roughly 7.24% of the company’s market cap and approximately 9.85% of the institutional ownership. Similar statistics are true for the second largest owner, Blackrock Inc., which owns 7,531,632 shares of the stock are valued at $390.06 million. The third largest holder is Wellington Management Group Llp, which currently holds $255.93 million worth of this stock and that ownership represents nearly 3.68% of its market capitalization.
At the end of 09/30/2017 reporting period, 138 institutional holders increased their position in Exact Sciences Corporation (NASDAQ:EXAS) by some 9,934,181 shares, 134 decreased positions by 12,760,649 and 41 held positions by 75,967,187. That puts total institutional holdings at 98,662,017 shares, according to SEC filings. The stock grabbed 49 new institutional investments totaling 1,746,367 shares while 34 institutional investors sold out their entire positions totaling 2,260,913 shares.Exact Sciences Corporation (NASDAQ:EXAS) Insider Trades
Multiple company employees have indulged in significant insider trading. Exact Sciences Corporation disclosed in a document filed with the US Securities and Exchange Commission (SEC) that President and CEO Conroy Kevin T has sold 123,512 shares of Exact Sciences Corporation (EXAS) in trading session dated Dec. 22, 2017. These shares are worth $6,494,261 and were traded at $52.58 each. The SEC filing shows that Conroy Kevin T performed a sale of 121,849 shares. The President and CEO disposed these shares by way of transaction on Dec. 06, 2017. The company’s shares were given away at $53.45 per share worth to an income of some $6,512,829 on account of Conroy Kevin T.
Chief Science Officer, Lidgard Graham Peter, sold 45,770 common shares of Exact Sciences Corporation (EXAS) in the open market. In a transaction dated Dec. 01, 2017, the shares were put up for sale at an average price of $58.27, raking in a sum of $2,667,018. After this sale, 205,963 common shares of EXAS are directly owned by the insider, with total stake valued at $11,498,914.
In the transaction dated Nov. 21, 2017, the great number of shares disposed came courtesy the President and CEO; Conroy Kevin T disposed a total of 134,057 shares at an average price of $59.5, amounting to approximately $7,976,392. The insider now directly owns 920,231 shares worth $51,376,497.Exact Sciences Corporation (EXAS) Analyst Guide
Several analysts have released their opinion on Exact Sciences Corporation (NASDAQ:EXAS), with 8 analysts believing it is a strong buy. Whereas 5 of them predict the stock is a hold. Also, there are 0 buy, 0 sell and 0 strong sell ratings, collectively assigning a 1.77 average brokerage recommendation.